Sigma Healthcare vs Sonic Healthcare shares: Which healthcare giant is the better buy?

Healthcare is a core slice of almost every Aussie portfolio, but the sector comes in many flavours. If you’re weighing up Sigma Healthcare Ltd (ASX: SIG) and Sonic Healthcare Ltd (ASX: SHL) shares, the decision boils down to more than just “pharma vs pathology.” Both are big names, both have national and global footprints, and each offers a very different blend of income, growth potential, and business risk. Here’s how they stack up.

The case for Sigma Healthcare

Sigma Healthcare is a stalwart of Australian pharmacy. Following its 2025 merger with Chemist Warehouse, Sigma now blends a massive wholesale pharmaceutical distribution network with the country’s biggest pharmacy retail footprint, operating well-known brands such as Chemist Warehouse, Amcal, and Discount Drug Stores. The company also backs up its retail network with services like dose administration aids and technology for pharmacy customers. According to its most recent company profile, Sigma was founded in 1912 and is based in Clayton, Victoria.

The numbers show Sigma as a sizable operation — its market cap clocks in at $28.86 billion, with 11.5 billion shares on issue. Current valuation looks lofty, trading at a price-to-earnings (P/E) ratio of 41.77. Dividends are there, but on the smaller end, with a yield of 1.54% and full 100% franking. Year to date, Sigma’s share price has slipped by 10.5%.

The case for Sonic Healthcare

Sonic Healthcare is a very different beast. Rather than retailing or wholesaling medication, Sonic is a diagnostics empire: the largest private pathology services operator in Australia, the UK, Germany, and Switzerland, plus big positions in the US, New Zealand, and Belgium. Pathology accounts for most of its revenue, but Sonic also boasts a leading role in diagnostic imaging and medical centre ownership in Australia.

Sonic has a market cap of $9.70 billion (much smaller than Sigma) and a P/E ratio of 15.89 — far lower than Sigma’s. For income-seekers, the dividend yield is a noticeable 5.53%, although franking is partial at 60%. It’s also seen a negative year-to-date return of 8.8%.

Valuation comparison

Here’s how the two stack up on key valuation and income metrics:

Metric	Sigma Healthcare	Sonic Healthcare
Market Cap	$28.86 billion	$9.70 billion
P/E Ratio	41.77	15.89
Dividend Yield	1.54% (100% franked)	5.53% (60% franked)
Earnings per Share (EPS)	0.062	1.106
Dividend per Share	0.04	1.08
Year to Date Return	-10.5%	-8.8%

Sigma’s larger market cap reflects its scale and sprawling retail network after merging with Chemist Warehouse. But it is Sonic that stands out on income, with a much higher dividend yield (and larger dividends per share), albeit with less franking. Sonic’s far lower P/E ratio suggests the market expects slower growth or sees less risk in Sigma, but sector differences make a like-for-like comparison tricky.

Recent share price performance

Both companies have faced a challenging run lately. Comparing 18 August – 17 September 2026:

• Sigma Healthcare shares fell from $2.93 to $2.50, including a steep single-day drop of 7.75% on 27 August 2026.
• Sonic Healthcare shares dropped from $23.02 to $19.62, also seeing some sharp daily declines — most notably a 9.25% fall on 20 August 2026.
• Year to date, Sigma is down 10.5%, while Sonic has slipped 8.8%.

So, both stocks have moved lower through 2026, with both hit by periods of strong selling.

Which is the better buy?

This is not a simple snap pick, but if I had to choose, I’d lean toward Sonic Healthcare as the more appealing buy right now.

Here’s why: Sonic’s dividend yield is meaningfully higher at 5.53%, and its payout is larger in absolute dollar terms. While the 60% franking won’t suit everyone seeking maximised after-tax income, it’s still a decent level. Sonic’s P/E ratio of 15.89 is far more attractive than Sigma’s 41.77, suggesting you’re paying much less per dollar of reported profit.

Sigma’s premium valuation might be justified given its dominant retail position after merging with Chemist Warehouse, opening up new earnings streams and scale — but that makes the stock look priced for strong ongoing growth, which isn’t fully backed up by its negative year-to-date returns.

Sonic’s business model is more defensive, with global operations and a central role in diagnostic healthcare. Its lower valuation, higher income, and solid EPS give me more confidence in its risk/reward, even after recent price weakness. Without meaningful trend data beyond this year’s snapshot, I can’t judge longer-term earnings or dividend growth for either company.

So, while Sigma is a genuine heavyweight with exciting exposure to Australian pharmacy retail, my pick for a buy today would be Sonic Healthcare for its income, global footprint, and lower relative valuation.

The post Sigma Healthcare vs Sonic Healthcare: Which ASX healthcare share wins? appeared first on The Motley Fool Australia.

More reading

• Down more than 18% in a month with a 7% yield, are Sonic Healthcare shares too cheap to ignore?
• ASX 200 healthcare shares lead a weaker market amid 82% chance of a rate hike
• 3 ASX shares I’d buy for income and growth in retirement
• How to build a superannuation portfolio generating $50,000 a year
• 9 ASX 200 shares earning strengthened buy ratings this week

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

CSL Ltd (ASX: CSL) shares are climbing again on Monday, with the healthcare giant continuing its strong rebound.

The CSL share price is up 1.29% to $177.85 in early afternoon trade after reaching an intraday high of $178.42.

That puts the stock right back near an area I’ve been watching closely on the chart.

CSL shares have now almost doubled from their 2026 low of $90, so a lot of the recovery has already happened.

And from a technical point of view, I think the next few dollars could be harder to come by.

Why $180 is a big level

The first thing that jumps out to me on the chart is the resistance sitting just below $180.

CSL shares have pushed into this area a few times recently, but so far haven’t been able to break through it.

And momentum is starting to look pretty stretched as well.

The relative strength index (RSI) is currently at 68, which is getting close to the 70 level generally considered overbought.

It doesn’t mean the share price has to fall from here, but I wouldn’t be surprised to see some selling around $180.

I think CSL may need another positive announcement or a decent market rally to properly break through this level.

If it can, the next major resistance level I’m watching on the chart is around $230.

Another risk is coming next week

There’s also another reason I wouldn’t be surprised to see CSL shares struggle around these levels.

The RBA meets again on 29 September, and another interest rate increase is looking increasingly likely.

According to Reuters, markets are now implying a 93% chance that the cash rate will rise from 4.35% to 4.60% at next week’s meeting.

That follows 3 rate hikes already this year, while RBA Governor Michele Bullock said last week that some of the upside risks to inflation were starting to materialise.

If the RBA does lift rates again, I wouldn’t be surprised to see some pressure come back into the ASX.

And with CSL already trading right around resistance, that could make breaking through $180 even harder.

Foolish takeaway

If I were looking at CSL today, I wouldn’t be rushing to chase the shares at $178.

The stock has already done a lot of the heavy lifting, and I’d rather see what happens around $180 before getting too excited.

A clean break above that level would be a much better signal to me than buying right underneath it.

For now, I’ll happily wait and see whether a pullback gives me a better entry point.

The post CSL shares are back near $180. Here’s the level I’m watching appeared first on The Motley Fool Australia.

More reading

• Why brokers think CSL shares could be on track for $200
• Buy, hold, sell: Coles, NAB, CSL shares
• ASX 200 healthcare shares lead a weaker market amid 82% chance of a rate hike
• How much passive income could I make by investing $500 a month in ASX shares?
• Are BHP, CBA, and CSL shares top buys?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

At age 59, you’re just one year from reaching preservation age, which means you can start drawing down on your superannuation if you’ve stopped working.

It’s one of the most important crossroads in life, and one where the decisions you’ll make over the next few years will determine the quality of life you have in retirement. 

But do you know what it costs to retire comfortably versus on a budget? And how much should you have in your super at age 59 to support yourself when the time comes?

Let’s take a look.

What does it cost to retire?

According to the Association of Superannuation Funds of Australia (ASFA) figures, there are two main options for your retirement. A comfortable retirement lifestyle, and a modest one.

A modest retirement means you’d need to live on a tight budget after you quit working. It assumes you can cover very basic needs and requirements, including basic food costs, enough to cover essential bills, low-tier health insurance, and minimal leisure activities or meals out. It assumes you own your home outright and that you’ll receive at least a partial Age Pension payment.

ASFA estimates this will cost single retirees around $36,434 per year, and closer to $52,473 for a couple combined. 

Then there is the comfortable retirement option. This is one that allows retirees to have a good standard of living well above the bare minimum. It allows Australians enough money to finance top-tier private health insurance, a reasonable grocery budget, home repairs, and regular leisure activities or meals out. It also includes a budget for an occasional holiday.

A comfortable retirement is estimated to cost single retirees around $55,923 per year or $78,566 for couples. Again, it assumes you’ll receive a part Age Pension and that you own your home in full. 

How much do I need in my superannuation to finance a comfortable retirement?

ASFA has calculated that single Australians will need around $630,000 in their superannuation, and couples will need around $730,000.

The catch is these figures assume that you’ll be retiring from age 67 and that you’ll need to fund around 10 to 15 years of retirement living. 

OK, so how much should I have in my superannuation at age 59 to reach this goal?

I’ve crunched the numbers using ASFA’s online super detective tool and, assuming you have an income of around $100,000 per year, Australians should aim to have a superannuation balance of around $434,500 by age 59. 

How does this compare to your own superannuation balance?

What if I want to retire a couple of years earlier at age 65? How much would I need to have today to be considered on track?

That’s very achievable, but you’d need to have enough in your superannuation at age 65 to fund those two extra years.

Your annual costs will be around the same: $55,923 per year for single Australians and $78,566 per year combined for a couple living together.

But, as I mentioned above, you’ll need to fund an additional two years above what ASFA accounts for.

That means, at age 65, singles will need to have around $742,000 in their superannuation, and couples will need a combined balance closer to $888,000 at the same age. 

To be considered on track for this amount at age 59, you’d need to have around $481,000 in your superannuation.

Is it possible to retire at age 60 and still live comfortably in retirement?

Yes. Again, this is very achievable if you have the funds to be able to support yourself for those additional seven years until age 67. 

At age 60, singles will need to have closer to $1 million in their superannuation. Meanwhile, couples will need a combined balance of around $1.3 million at the same age.

That means that at age 59, your superannuation balance should be very close to these levels. If not, you’d have just one year to make up the difference.

The post How much should I have in my superannuation at age 59? appeared first on The Motley Fool Australia.

More reading

• BHP shares are up 53%. Here are 5 reasons why they may not be done yet
• Why is this ASX gold share rocketing 7% on Monday?
• Is Life360 one of the best ASX growth shares to buy?
• Codan shares hit a new record high after the company predicts another strong year
• Why I’d invest $10,000 in these strong Vanguard ETFs

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.